Abstract:Diverse clinical presentations of clear cell renal cell carcinoma (ccRCC) confound clinical decision making, leading to over and undertreatment. Clonal evolution of ccRCC proceeds through distinct trajectories characterised by differing levels of genomic intratumoral heterogeneity (gITH) and chromosomal complexity (weighted genomic instability index, wGII). However, accurate evaluation of these indices requires multiregional profiling of fresh tumour; cost prohibitive and logistically challenging in the clinical setting. Clinical histopathology workflows routinely capture multiple tumour areas enabling the use artificial intelligence (AI) to predict tumour evolutionary features directly from clinical grade H&E whole slide image (WSIs). ccRCC displays profound genetic and histological ITH but the link between these entities remains unclear. We leverage the TRACERx Renal cohort, comprising 1485 WSIs from 81 tumours to predict WGII and gITH and to gain insights into the relationship between genetic and histological ITH. Critically, each WSI is associated with a wGII and gITH label derived from a closely linked fresh tumour sample. For both prediction tasks, we extracted meaningful features for each WSI using self-supervised representation learning "MoCo". Since high wGII confers poor prognosis we focussed on predicting binary stratification label of high wGII or low wGII (relative to the cohort median). First we predicted wGII as a continuous variable using a supervised multiple instance learning regression model trained on the MoCo features, and then classified the predicted wGII into "high" or "low" achieving 0.80 AUROC. To predict gITH we postulated that the degree of gITH would correlate with histological ITH. Using an unsupervised clustering of refined MoCo features we defined 24 histological clusters. The number of computationally derived histological clusters within a single tumour positively correlated with gITH (pearson's 0.56). We used the number of clusters to classify WSIs into prognostic binary groups of high or low gITH (relative to the cohort median) achieving an AUROC of 0.80. To understand the biological relationship between histological and genetic ITH we pathologically characterised the histological clusters: a pathologist annotated WSIs with tumour architecture and cytomorphology. Image tiles were associated with the annotations using spatial coordinates, illuminating phenotypic traits of different evolutionary trajectories and providing an interpretability framework for our AI pipelines. Since the tumour evolutionary course dictates disease progression tempo, applying evolutionary classification in clinic can fundamentally improve patient care. Here, for the first time, we provide a framework to translate fundamental evolutionary principles underpinning tumour biology and clinical progression into a prognostic computational pathology biomarker possible to clinically implement. Citation Format: Charlotte E. Spencer, Axel Camara, Auriane Riou, Lewis Au, Jose I. Lopez, Zayd Tippu, Charles Maussion, Kenneth Ho, Amy Strange, Emma Nye, Veronique Birault, Lydwine Van-praet, Kim Edmonds, Eleanor Carlyle, Steve Hazell, Sarah Rudman, James Larkin, Samra Turajlic. Predicting tumor evolution from digital histology using AI [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4298.

Abstract PR005: Deep learning-based multimodal integration of histology and genomics improves cancer origin prediction

Abstract 5045: Genomics and pathology based deep learning to predict cancers of unknown primary

Diagnostic efficacy of deep learning-based prediction of origin for patients with cancers of unknown primary.

Deep Learning-based Computational Pathology Predicts Origins for Cancers of Unknown Primary

Abstract 4951: Integrative multi-omic machine learning model predicts neoadjuvant immunotherapy response using molecular data and deep learning-derived features from digital pathology

Abstract 2310: Integrating real-world histopathological and clinicogenomic data from 1799 lung cancer patients by applying unsupervised deep learning

Abstract 4331: Machine learning-based classification of tissue origin of cancer using methylation profiles

Abstract 896: Predicting metastatic transcriptomes of patient tumors with deep learning

Abstract 4970: Multi-modal machine learning approaches for predicting cancer type and Gleason grade leveraging public TCGA data

Identifying the Origination of Liver Metastasis Using a Hand-Crafted Computational Pathology Approach

Abstract 2313: Multi-modal deep learning to predict cancer outcomes by integrating radiology and pathology images

An Accurate Prediction of the Origin for Bone Metastatic Cancer Using Deep Learning on Digital Pathological Images.

Identifying Primary Tumor Site of Origin for Liver Metastases Via a Combination of Handcrafted and Deep Learning Features.

Abstract 7380: Predicting immunotherapy outcomes from H&E images in lung cancer

Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation

Abstract B082: Early risk stratification of ER+/HER2– breast cancer patients using digital pathology and multi-task, weakly-supervised deep learning

A Deep Learning System to Predict Origins for Cancers of Unknown Primary Using Cytological Images from Hydrothorax and Ascites

The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review

Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer

Abstract 4298: Predicting tumor evolution from digital histology using AI

Abstract 5440: Deep-learning model for tumor type classification enables enhanced clinical decision support in cancer diagnosis